News
FOPE urges Centre to provide compensation to Kusum Healthcare: Nandita Vijayasimha, Bengaluru Wednesday, April 23, 2025, ...
Nandita Vijayasimha, Bengaluru Wednesday, April 23, 2025, 08:00 Hrs [IST] ...
UTs did not submit NSQ data with Centre in March: Gireesh Babu, New Delhi Wednesday, April 23, 2025, 08:00 Hrs [IST] The number of states failing to submit the mon ...
Haryana CM assures industry of change in pharma policy to expedite Karnal Pharma Park: Peethaambaran Kunnathoor, Chennai Wednesday, April 23, 2025, 08:00 Hrs [IST] RL Sharma, the ...
Ever since the Narendra Modi-led BJP government came to power in the year 2014, there have been renewed talk of an exclusive Union ministry for pharmaceuticals and medical devices. There can be no two ...
DGFT introduces new field in eBRCs to track service exports from May 1: Shardul Nautiyal, Mumbai Wednesday, April 23, 2025, 08:00 Hrs [IST] The Directorate General of Foreign Trad ...
BD introduces next generation hemodynamic monitoring solution providing clinicians with AI-driven clinical decision support: ...
Fujifilm India unveils ELUXEO 8000 Therapeutic Endoscopy Solution: Our Bureau, Bengaluru Tuesday, April 22, 2025, 09:00 Hrs ...
China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...
Dr Batra’s Healthcare expands global footprint with launch of a virtual Homoeopathy clinic in Malaysia: Our Bureau, Bengaluru Tuesday, April 22, 2025, 14:15 Hrs [IST] Dr Batras ...
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the US over the next five years
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the US over the next five years: Basel Tuesday, April 22, 2025, 17:00 Hrs [IST] Roche announced that it will i ...
ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results